Both in Pharmaceuticals
Alumis vs Aktis Oncology
Over the past year ALMS returned −66.7% and AKTS returned −32.8%; their daily moves had a correlation of 0.15.
ALMS −66.7% AKTS −32.8%Growth of $1, one year, split-adjusted
| Metric | ALMS | AKTS |
|---|---|---|
| Price | $6.51 | $15.06 |
| Market cap | $842.6M | $837.4M |
| Today | +0.15% | +0.77% |
| 1 month | −6.1% | −15.7% |
| 6 months | −74.5% | −24.8% |
| Year to date | −33.3% | — |
| 1 year | +42.8% | — |
| Revenue growth (YoY) | −37.7% | — |
| Gross margin | 100.0% | 100.0% |
| Net margin | −8557.2% | −713.5% |
| P/E (TTM) | — | — |
| Price / sales | 113.9× | — |
| Net cash | $502.3M | $517.3M |
| Dividend yield | — | — |
| Volatility (60d) | 180.1% | 55.1% |
| Short % of float | 11.3% | 18.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).